7Vote!
CommonDreams.org Headlines (Free subscription) | 11/12/2009
by Julie Steenhuysen CHICAGO - A study of internal company documents suggests Pfizer Inc altered or omitted unfavorable study findings to expand its epilepsy drug Neurontin's market, U.S. researchers said on Wednesday, offering a look at how drugmakers influence scientific research. Clinical trials are supposed to answer a specific, predetermined scientific question, but a comparison...
3Vote!
Avian Flu Diary (Free subscription) | 11/04/2009
... the abstract below that. Swine flu not just a threat to young: study Tue Nov 3, 2009 5:22pm EST By Julie Steenhuysen CHICAGO (Reuters) - Swine flu can cause severe disease in people of all ages and appears to pose a special threat to those who are obese, according to an analysis of H1N1 cases in California released on Tuesday. Public health researchers analyzed the state's first 1,088...
5Vote!
Avian Flu Diary (Free subscription) | 10/15/2009
... study has received some mainstream media press over the past 24 hours, with a Reuters piece by Julie Steenhuysen widely reprinted around the world. Study explains immunity to H1N1 in older people Wed Oct 14, 2009 5:51pm EDT By Julie Steenhuysen CHICAGO (Reuters) - Older people who have been infected with or vaccinated against seasonal flu may have a type of immunity...
3Vote!
Health - The Post Chronicle (Free subscription) | 10/08/2009
... 3 billion doses a year -- not enough to cover the population of 6.8 billion people.(Reporting by Julie Steenhuysen; Editing by Maggie Fox)
3Vote!
Reuters UK (Free subscription) | 10/08/2009
... 3 billion doses a year -- not enough to cover the population of 6.8 billion people.(Reporting by Julie Steenhuysen; Editing by Maggie Fox)
5Vote!
Reuters (Free subscription) | 10/08/2009
... 3 billion doses a year -- not enough to cover the population of 6.8 billion people.(Reporting by Julie Steenhuysen; Editing by Maggie Fox)
